InnovAge Holding Corp. (NASDAQ:INNV – Free Report) – Stock analysts at William Blair raised their Q3 2025 earnings per share estimates for InnovAge in a research report issued to clients and investors on Tuesday, February 4th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of ($0.01) for the quarter, up from their previous estimate of ($0.02). The consensus estimate for InnovAge’s current full-year earnings is ($0.06) per share. William Blair also issued estimates for InnovAge’s FY2025 earnings at ($0.15) EPS and FY2026 earnings at $0.08 EPS.
InnovAge (NASDAQ:INNV – Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.10) earnings per share for the quarter. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%.
View Our Latest Analysis on InnovAge
InnovAge Stock Performance
INNV opened at $3.29 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.21 and a current ratio of 1.21. The stock has a market capitalization of $444.95 million, a price-to-earnings ratio of -27.42 and a beta of 0.37. The company has a fifty day moving average of $4.01 and a 200 day moving average of $5.21. InnovAge has a fifty-two week low of $3.12 and a fifty-two week high of $6.69.
Institutional Investors Weigh In On InnovAge
A number of hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in shares of InnovAge by 5.5% in the 3rd quarter. Geode Capital Management LLC now owns 527,955 shares of the company’s stock worth $3,168,000 after buying an additional 27,304 shares in the last quarter. Barclays PLC grew its position in InnovAge by 289.0% in the third quarter. Barclays PLC now owns 25,614 shares of the company’s stock worth $154,000 after acquiring an additional 19,029 shares in the last quarter. JPMorgan Chase & Co. increased its stake in InnovAge by 191.5% during the third quarter. JPMorgan Chase & Co. now owns 24,687 shares of the company’s stock worth $148,000 after acquiring an additional 16,217 shares during the last quarter. SG Americas Securities LLC bought a new stake in InnovAge during the fourth quarter worth approximately $43,000. Finally, Charles Schwab Investment Management Inc. raised its position in InnovAge by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 165,531 shares of the company’s stock valued at $993,000 after purchasing an additional 6,153 shares during the period. Hedge funds and other institutional investors own 12.26% of the company’s stock.
InnovAge Company Profile
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Recommended Stories
- Five stocks we like better than InnovAge
- Retail Stocks Investing, Explained
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- How Can Investors Benefit From After-Hours Trading
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- 3 Small Caps With Big Return Potential
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.